Vitrolife AB (publ), a medical device company, develops, produces, and markets products for assisted reproduction. It provides oocyte retrieval needles; sperm processing; in vitro fertilization media and oil; micromanipulation pipettes; labware; incubators; cryopreservation; and preimplantation genetic testing products. The company also offers EmbryoScope and Primo Vision time-lapse systems; time-lapse dishes; evaluation tools for time-lapse systems; and Octax laser and imaging systems, as well as log and guard systems and wireless sensors. It operates in Europe, the Middle East, and Africa; Asia; Japan and Pacific; and North and South America. The company was formerly known as Scandinavian IVF Science and changed its name to Vitrolife AB (publ) in 1998. Vitrolife AB (publ) was founded in 1994 and is headquartered in Gothenburg, Sweden.
Vitrolife Dividend Announcement
• Vitrolife announced a annually dividend of kr1.00 per ordinary share which will be made payable on 2024-05-03. Ex dividend date: 2024-04-26
• Vitrolife annual dividend for 2024 was kr1.00
• Vitrolife annual dividend for 2023 was kr0.85
• Vitrolife's trailing twelve-month (TTM) dividend yield is 0.46%
• Vitrolife's payout ratio for the trailing twelve months (TTM) is -3.55%
• Vitrolife's dividend growth over the last five years (2018-2023) was -25.49% year
• Vitrolife's dividend growth over the last ten years (2013-2023) was 3.54% year
Vitrolife Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-04-26 | kr1.00 | annually | 2024-05-03 |
2023-04-28 | kr0.85 | annually | 2023-05-05 |
2022-04-28 | kr0.80 | annually | 2022-05-04 |
2021-04-29 | kr0.80 | annually | 2021-05-05 |
2020-04-29 | kr1.05 | annually | |
2019-05-03 | kr0.85 | annually | 2019-05-09 |
2018-04-27 | kr3.70 | annually | 2018-05-04 |
2017-04-28 | kr2.60 | annually | 2017-05-05 |
2016-04-29 | kr2.40 | annually | |
2015-05-06 | kr1.50 | annually | |
2014-05-06 | kr1.00 | annually | |
2013-04-30 | kr0.60 | annually |
Vitrolife Dividend per year
Vitrolife Dividend growth
Vitrolife Dividend Yield
Vitrolife current trailing twelve-month (TTM) dividend yield is 0.46%. Interested in purchasing Vitrolife stock? Use our calculator to estimate your expected dividend yield:
Vitrolife Financial Ratios
Vitrolife Dividend FAQ
Other factors to consider when evaluating Vitrolife as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Vitrolife stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Vitrolife's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Vitrolife publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Vitrolife distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Vitrolife are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Vitrolife sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Vitrolife distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Vitrolife declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Vitrolife's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Vitrolife's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.